| [1] |
LANGE C, BÖTTGER E C, CAMBAU E, et al. Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases[J]. Lancet Infect Dis, 2022, 22(7):e178-e190.
|
| [2] |
WANG J, HUANG J, PENG S, et al. A clinical case and a review of Mycobacterium fortuitum infections direct diagnosis approach and treatment in a patient with leg fractures[J]. J Infect Dev Ctries, 2022, 16(10):1650-1654.
|
| [3] |
OPPERMAN C, HARRICOMBE W, SINGH S, et al. Isolation of pure non-tuberculous mycobacteria culture from a mixed growth with conventional microbiology:techniques not to be forgotten[J]. Indian J Tuberc, 2024, 71(3):235-237.
|
| [4] |
李永事, 黄赛林. 偶发分枝杆菌致术后颅内感染1例[J]. 中国临床神经外科杂志, 2022, 27(2):143.
|
| [5] |
程丽平. 非结核分枝杆菌病分子生物学诊断专家共识[J]. 中国防痨杂志, 2025, 47(8):961-975.
|
| [6] |
杨婷婷. BALF宏基因组二代测序在肺部感染病原体诊断中的应用价值[D]. 大理: 大理大学, 2025.
|
| [7] |
余黎君, 刘伯萸, 赵婷. 双膝关节置换术后合并脓肿分枝杆菌感染患者一例的护理体会[J]. 军事护理, 2022, 39(11):92-93.
|
| [8] |
初乃惠, 周文强, 沙巍. 非结核分枝杆菌病治疗药品超说明书用法专家共识[J]. 中国防痨杂志, 2020, 42(8):769-787.
|
| [9] |
何广成, 江慧贤, 李祥, 等. 临床药师参与1例皮肤非结核分枝杆菌感染患者的药疗实践[J]. 现代医院, 2019, 19(3):454-455.
|
| [10] |
DAHL V N, PEDERSEN A A, NORMAN A, et al. Clinical significance,species distribution,and temporal trends of nontuberculous Mycobacteria,Denmark,1991-2022[J]. Emerg Infect Dis, 2024, 30(9):1755-1762.
|
| [11] |
HAN S A, KO Y, SHIN S J, et al. Characteristics of circulating CD4+ T cell subsets in patients with mycobacterium avium complex pulmonary disease[J]. J Clin Med, 2020, 9(5):1331.
|
